Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPAL: Online Prehabilitation for Patients Awaiting Liver Transplantation - a Multicenter Randomized Controlled Trial to Reduce Physical Frailty and Improve Health Outcomes

NCT05899231 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05899231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPAL: Online Prehabilitation for Patients Awaiting Liver Transplantation - a Multicenter Randomized Controlled Trial to Reduce Physical Frailty and Improve Health Outcomes
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Recruiting
Start date
July 12, 2023
Completion date
September 30, 2026
Enrollment
177 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, liver disease, liver transplant surgery